The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J.-M. A., Hammer, R. E., & Mangelsdorf, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81432-4 · Cited by 1,436
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,234
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., & Evans, R. M. (1992) · Genes & Development · doi:10.1101/gad.6.3.329 · Cited by 1,190
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Gigleux, S. F., Green, M., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,183
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
NEBERT, D. W., NELSON, D. R., COON, M. J., ESTABROOK, R. W., FEYEREISEN, R., FUJII-KURIYAMA, Y., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., et al. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.1 · Cited by 1,094
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 1×
“…et aL recently shown that two of the 15 cysteine residues (Cys273 and Cys288) in Keapl may play an important role in releasing Nrf2 in response to electrophiles and oxidative stress via the formation of an intermolecular disulfide bridge, at least in the test tube (Wakabayashi et aL, 2004).”
BackgroundKast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 815
König, J., Nies, A. T., Cui, Y., Leier, I., & Keppler, D. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 791
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Waxman, D. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1351 · Cited by 753
Cullinan, S. B., & Diehl, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314219200 · Cited by 744
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Humanized xenobiotic response in mice expressing nuclear receptor SXR
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., & Evans, R. M. (2000) · Nature · doi:10.1038/35019116 · Cited by 660
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Aryl hydrocarbon receptors: diversity and evolution
Hahn, M. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00070-4 · Cited by 642
Benzo[ a ]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., & Ishikawa, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.779 · Cited by 633
Nguyen, T., Sherratt, P. J., Huang, H.-C., Yang, C. S., & Pickett, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207293200 · Cited by 615
Kwak, M.-K., Itoh, K., Yamamoto, M., & Kensler, T. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2883-2892.2002 · Cited by 593
Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., & Talalay, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051632198 · Cited by 590
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
Nrf2 is essential for protection against acute pulmonary injury in mice
Chan, K., & Kan, Y. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12731 · Cited by 574
Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene
Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., & Negishi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6318 · Cited by 549
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220418997 · Cited by 539
Evolution of the P450 gene superfamily:
Gonzalez, F. J., & Nebert, D. W. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90174-5 · Cited by 514
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
König, J., Rost, D., Cui, Y., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 504
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503
Aryl Hydrocarbon Receptor-Mediated Signal Transduction
Rowlands, J. C., & Gustafsson, J.-Å. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709021615 · Cited by 497
Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., & Moore, D. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1544 · Cited by 494
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Stewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Antioxidants and oxidants regulated signal transduction pathways
Owuor, E. D., & Kong, A.-N. T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01137-1 · Cited by 439
Self-citationThe structure of the nuclear hormone receptors
Kumar, R., & Thompson, E. B. (1999) · Steroids · doi:10.1016/s0039-128x(99)00014-8 · Cited by 435
King, C., Rios, G., Green, M., & Tephly, T. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339171 · Cited by 432
Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes
Rushmore, T. H., & Kong, A.-N. T. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337171 · Cited by 424
Self-citationRushmore, T. H., King, R. G., Paulson, K. E., & Pickett, C. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3826 · Cited by 423
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Chen, C., Yu, R., Owuor, E. D., & Tony Kong, A. N. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02975249 · Cited by 403
Gilde, A. J., van der Lee, K. A. J. M., Willemsen, P. H. M., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., & van Bilsen, M. (2003) · Circulation Research · doi:10.1161/01.res.0000060700.55247.7c · Cited by 399
Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.-H., Owens, I. S., Negishi, M., & Sueyoshi, T. (2001) · Hepatology · doi:10.1053/jhep.2001.24172 · Cited by 381
Nomenclature for N-acetyltransferases
Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J., Evans, D. A. P., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U., Relling, M. V., et al. (1995) · Pharmacogenetics · doi:10.1097/00008571-199502000-00001 · Cited by 379
Cytochromes P450, Drugs, and Diseases
Guengerich, F. P. (2003) · Molecular Interventions · doi:10.1124/mi.3.4.194 · Cited by 378
The aryl hydrocarbon receptor: studies using the AHR-null mice.
Gonzalez, F. J., & Fernández‐Salguero, P. M. (1998) · PubMed · Cited by 375
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369
Jelinek, D. F., Andersson, S., Slaughter, C. A., & Russell, D. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39056-8 · Cited by 367
Phenobarbital Response Elements of Cytochrome P450 Genes and Nuclear Receptors
Sueyoshi, T., & Negishi, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.123 · Cited by 362
Yu, R., Chen, C., Mo, Y.-Y., Hebbar, V., Owuor, E. D., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004037200 · Cited by 340
Self-citationTurgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333
Kwak, M.-K., Itoh, K., Yamamoto, M. P., Sutter, T. R., & Kensler, T. W. (2001) · PubMed Central · Cited by 330
Pascussi, J. M., Gerbal-Chaloin, S., Drocourt, L., Maurel, P., & Vilarem, M. J. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00483-x · Cited by 330
Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 316
Self-citationKwak, M.-K., Itoh, K., Yamamoto, M., Sutter, T. R., & Kensler, T. W. (2001) · Molecular Medicine · doi:10.1007/bf03401947 · Cited by 306
The cytochrome P450 4 (CYP4) family
Simpson, A. E. C. M. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00246-7 · Cited by 298
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., & Kong, A.-N. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27545 · Cited by 281
Self-citationOverview of enzymes of drug metabolism
Meyer, U. A. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353473 · Cited by 279
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 278
Kong, A.-N. T., Yu, R., Chen, C., Mandlekar, S., & Primiano, T. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976458 · Cited by 274
Self-citationKang, K. W., Lee, S. J., Park, J. W., & Kim, S. G. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1001 · Cited by 274
The Complexities of Hepatic Drug Transport: Current Knowledge and Emerging Concepts
Chandra, P., & Brouwer, K. L. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026420.79421.8f · Cited by 266
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 266
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Staudinger, J. L., Liu, Y., Madan, A., Habeebu, S. S., & Klaassen, C. D. (2001) · PubMed · Cited by 260
Transcriptional Regulation of the Human CYP3A4Gene by the Constitutive Androstane Receptor
Goodwin, B., Hodgson, E., D'Costa, D. J., Robertson, G. R., & Liddle, C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.359 · Cited by 254
Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators
Gervois, P., Torra, I. P., Fruchart, J.-C., & Staels, B. (2000) · cclm · doi:10.1515/cclm.2000.002 · Cited by 249
Zetterstrom, R. H. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1656 · Cited by 246
Wei, P., Zhang, J., Dowhan, D. H., Han, Y., & Moore, D. D. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500087 · Cited by 240
Lee, J.-M., Hanson, J. M., Chu, W. A., & Johnson, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100734200 · Cited by 228
Hu, R., Hebbar, V., Kim, B.-R., Chen, C., Winnik, B., Buckley, B., Soteropoulos, P., Tolias, P., Hart, R. P., & Kong, A.-N. T. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064261 · Cited by 219
Self-citationWang, H., Faucette, S., Sueyoshi, T., Moore, R., Ferguson, S., Negishi, M., & LeCluyse, E. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212482200 · Cited by 215
Localization and function of the organic anion–transporting polypeptide Oatp2 in rat liver
Reichel, C., Gao, B., van Montfoort, J., Cattori, V., Rahner, C., Hagenbuch, B., Stieger, B., Kamisako, T., & Meier, P. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70463-4 · Cited by 214
Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., & Klaassen, C. D. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.97 · Cited by 212
ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
Kerb, R., Hoffmeyer, S., & Brinkmann, U. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.51 · Cited by 202
Organic anion‐transporting polypeptide (OATP) transporter family and drug disposition
Kim, R. B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.5.x · Cited by 200
Lambe, K. G., & Tugwood, J. D. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0001u.x · Cited by 198
Yu, R., Mandlekar, S., Lei, W., Fahl, W. E., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2322 · Cited by 196
Self-citationRegulation of Nrf2 Transactivation Domain Activity
Shen, G., Hebbar, V., Nair, S., Xu, C., Li, W., Lin, W., Keum, Y.-S., Han, J., Gallo, M. A., & Kong, A.-N. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401368200 · Cited by 194
Self-citationBeigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00196-1 · Cited by 192
Yu, S., Rao, S., & Reddy, J. K. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479537 · Cited by 184
Drug-activated nuclear receptors CAR and PXR
Honkakoski, P., Sueyoshi, T., & Negishi, M. (2003) · Annals of Medicine · doi:10.1080/07853890310008224 · Cited by 180
Signal transduction events elicited by cancer prevention compounds
Kong, A.-N. T., Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., Ee, R., & Mandlekar, S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00182-8 · Cited by 169
Self-citationHeme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2
Alam, J., Killeen, E., Gong, P., Naquin, R., Hu, B., Stewart, D., Ingelfinger, J. R., & Nath, K. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00376.2002 · Cited by 167
Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Schimizu, Y. (2000) · Medical Entomology and Zoology · Cited by 164
Honkakoski, P., Moore, R., Washburn, K. A., & Negishi, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.597 · Cited by 162
Keum, Y.-S., Owuor, E. D., Kim, B.-R., Hu, R., & Kong, A.-N. T. (2003) · Pharmaceutical Research · doi:10.1023/a:1025737622815 · Cited by 161
Self-citationHaplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
Innocenti, F., Grimsley, C., Das, S., Ramírez, J., Cheng, C., Kuttab-Boulos, H., Ratain, M. J., & Rienzo, A. D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200212000-00006 · Cited by 159
Ferguson, S. S., LeCluyse, E. L., Negishi, M., & Goldstein, J. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.737 · Cited by 158
Khan, S. A., & Heuvel, J. P. V. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00098-6 · Cited by 154
Regulation of Drug Transporter Gene Expression by Nuclear Receptors
Staudinger, J. L., Madan, A., Carol, K. M., & Parkinson, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.523 · Cited by 152
Huang, X., Powell‐Coffman, J. A., & Jin, Y. (2004) · Development · doi:10.1242/dev.00959 · Cited by 149
INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
Teng, S., Jekerle, V., & Piquette‐Miller, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1296 · Cited by 148
Peroxisome Proliferator‐activated Receptors: Stuctures and Function
Tugwood, J. D., Aldridge, T. C., Lambe, K. G., MACDONALD, N., & Woodyatt, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18620.x · Cited by 145
Characterization of a Phenobarbital-responsive Enhancer Module in Mouse P450 Cyp2b10 Gene
Honkakoski, P., & Negishi, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14943 · Cited by 142
Polymorphisms in the ABC drug transporter gene MDR1
Brinkmann, U., & Eichelbaum, M. F. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500001 · Cited by 141
Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells
Li, W., Harper, P. A., Tang, B.-K., & Okey, A. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00208-1 · Cited by 135
Guo, G. L., Staudinger, J. L., Ogura, K., & Klaassen, C. D. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.832 · Cited by 127
Heid, S. E., Pollenz, R. S., & Swanson, H. I. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26445-2 · Cited by 122
Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes
Inokuchi, A., Hinoshita, E., Iwamoto, Y., Kohno, K., Kuwano, M., & Uchiumi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104612200 · Cited by 121
PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides
Coumoul, X., Diry, M., & Barouki, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01298-4 · Cited by 118
GST function in drug and stress response
Tew, K. D., & Ronai, Z. A. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0086 · Cited by 115
Ritter, J. K., Kessler, F. K., Thompson, M. T., Grove, A. D., Auyeung, D. J., & Fisher, R. A. (1999) · Hepatology · doi:10.1002/hep.510300205 · Cited by 112
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
Tirona, R. G., & Kim, R. B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00077-7 · Cited by 112
Shitara, Y., Sugiyama, D., Kusuhara, H., Kato, Y., Abe, T., Meier, P. J., Itoh, T., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1014264614637 · Cited by 107
Xiong, H., Yoshinari, K., Brouwer, K. L. R., & Negishi, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.918 · Cited by 95
Regulation of Drug and Bile Salt Transporters in Liver and Intestine
Kullak-Ublick, G. A., & Becker, M.-B. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026398 · Cited by 93
Nakajima, M. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00216-9 · Cited by 84
Protection Against Cancer by Plant Phenylpropenoids: Induction of Mammalian Anticarcinogenic Enzymes
Dinkova‐Kostova, A. T. (2002) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557023405558 · Cited by 82
Menke, J. G., MacNaul, K. L., Hayes, N. S., Baffic, J., Chao, Y., Elbrecht, A., Kelly, L. J., Lam, M., Schmidt, A., Sahoo, S. P., et al. (2002) · Endocrinology · doi:10.1210/endo.143.7.8907 · Cited by 82
Fraser, D. J., Zumsteg, A., & Meyer, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306148200 · Cited by 81
del Castillo‐Olivares, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3587 · Cited by 81
Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats
Perloff, M. D., Moltke, L. L., & Greenblatt, D. J. (2004) · Xenobiotica · doi:10.1080/00498250310001630215 · Cited by 71
Wolters, H., Elzinga, B. M., Baller, J. F. W., Boverhof, R., Schwarz, M., Stieger, B., Verkade, H. J., & Kuipers, F. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00247-7 · Cited by 67
Guo, G. L., Choudhuri, S., & Klaassen, C. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.206 · Cited by 66
P450 structures and oxidative metabolismof xenobiotics
Lewis, D. F. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.4.387.22752 · Cited by 65
Bae, Y., Kemper, J. K., & KEMPER, B. W. (2004) · DNA and Cell Biology · doi:10.1089/104454904322759894 · Cited by 64
Pathophysiological Factors Affecting CAR Gene Expression
Pascussi, J., Dvořák, Z., Gerbal‐Chaloin, S., Assénat, E., Maurel, P., & Vilarem, M. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026394 · Cited by 63
Aryl hydrocarbon receptor-mediated cell cycle control.
Elferink, C. J. (2003) · PubMed · Cited by 62
Structure of the rat gene encoding cholesterol 7.alpha.-hydroxylase
Jelinek, D. F., & Russell, D. W. (1990) · Biochemistry · doi:10.1021/bi00486a001 · Cited by 60
Gao, B., Wenzel, A., Grimm, C., Vavricka, S. R., Benke, D., Meier, P. J., & Remé, C. E. (2002) · PubMed · doi:10.7270/q2988883 · Cited by 54
Song, X., Xie, M., Zhang, H., Li, Y., Sachdeva, K., & Yan, B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.1.35 · Cited by 54
Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression
Jaiswal, A. K. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00001 · Cited by 49
Glutathione-related enzymes, glutathione and multidrug resistance
Moscow, J. A., & Dixon, K. H. (1993) · Cytotechnology · doi:10.1007/bf00744663 · Cited by 44
Kikuchi, Y., Ohsawa, S., Mimura, J., Ema, M., Takasaki, C., Sogawa, K., & Fujii-Kuriyama, Y. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg115 · Cited by 42
Phase II enzymes and bioactivation
Hinson, J., & Forkert, P. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-196 · Cited by 41
Bock, K. W., Gschaidmeier, H., Heel, H., Lehmköster, T., Münzel, P., Raschko, F. T., & Bock-Hennig, B. S. (1998) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(97)00013-7 · Cited by 40
Ramsden, R., Beck, N. B., Sommer, K. M., & Omiecinski, C. J. (1999) · Gene · doi:10.1016/s0378-1119(98)00612-x · Cited by 38
Mahéo, K., Antras‐Ferry, J., Morel, F., Langouët, S., & Guillouzo, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16125 · Cited by 34
Zhou, Y.-C., Davey, H. W., McLachlan, M. J., Xie, T., & Waxman, D. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9426 · Cited by 22
Schilter, B., Turesky, R. J., Juillerat, M., Honegger, P., & Guigoz, Y. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90253-s · Cited by 19
Levine, S. L., & Perdew, G. H. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.557 · Cited by 17
Quinoids as Reactive Intermediates in Estrogen Carcinogenesis
Bolton, J. L., & Chang, M. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_75 · Cited by 14
Transcriptional Regulation of the Rat Mrp3 Promoter in Intestine Cells
Tzeng, S.-J., & Huang, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6442 · Cited by 10
Cited by
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
Metadata
- Authors
- Xu, C., Li, C. Y.-T., & Kong, A.-N. T.
- Venue
- Archives of Pharmacal Research
- Published
- 2005-03
- Volume
- 28
- Issue
- 3
- Pages
- 249-268
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W2044911368
- Cited by
- 1,279
- References
- 154
- FWCI
- 41.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.